Successful exit for D11Z. Ventures with HEUKING

A HEUKING team, led by Stuttgart-based Partner Dr. Hermann Ali Hinderer, comprehensively advised Heilbronn-based venture capitalist D11Z. Ventures on legal and tax matters related to the company’s structured exit process from seleon GmbH. Going forward, seleon will be part of the aesco solutions group of companies. Both seleon and aesco operate in the CDMO (Contract Development and Manufacturing Organization) sector, and the merger will enhance their range of services in the Life Sciences sector.

D11Z. Ventures is an early-stage investor focused on digital business models in AI/deep tech, B2B SaaS, and asset-light IoT. The single-family office promotes and supports sustainable digital innovations and visionary entrepreneurship both nationally and internationally. Its objective is to position itself as the most innovative pre-seed and seed VC fund for AI in Europe.

Founded in 1998 and headquartered in Heilbronn, with additional sites in Dessau and Leipzig, seleon GmbH has established itself as a leading service partner in Central Europe for the development of medical technology devices and assemblies. The company specializes in fluidics applications and offers clinical and regulatory consulting. At its production site in Dessau, seleon manufactures high-quality devices for renowned medical technology companies.

aesco Solutions is a full-service provider specializing in medical technology, in-vitro diagnostics, and laboratory technology. The company excels in developing and producing highly complex electronic and mechatronic systems.

Counsel to D11Z. Ventures
HEUKING:
Dr. Hermann Ali Hinderer, LL.M. (Lead, Corporate / M&A), Stuttgart,
Fabian G. Gaffron (Tax),
Dr. Frederik Wiemer (Antitrust), both Hamburg,
Marcel Behrendt (Corporate / M&A),
Carina Bart (Employment), both Stuttgart